Our Mission: Zero time waiting lists for kidney patientsDialysis patients stay for years on a kidney transplant waiting list with a very low quality of life, risking death and generating high costs to the community.
Our Mission: Zero time waiting lists for kidney patients
Dialysis patients stay for years on a kidney transplant waiting list with a very low quality of life, risking death and generating high costs to the community.
Our Vision & Mission
Advances in medicine have led to greater success in transplantation. On the other hand, an ageing society led to increasing numbers of patients on transplant waiting lists. Accordingly, availability of organs is less than adequate, and organ shortage has resulted in many cases of death.
For end-stage renal disease a kidney transplantation is the optimal therapy. Patients’ quality of life is increased, average life expectancy is prolonged, and healthcare costs are reduced. Today, due to shortage of transplant kidneys, each year many patients die, and many more suffer the debilitating effects of dialysis.
Our vision is to improve transparency and efficiency of organ transplantation workflows by democratizing access to state of the art medicine and boosting organ donations.
Our first mission is to boost organ donations by enabling citizens to create, manage, connect and execute their digital living wills on our platform.
The medical need
Dialysis patients stay for years on kidney transplant waiting lists with low quality of life, risking death and generating high costs.
Kidney transplantation offers significant advantages compared to prolonged dialysis.
Increased life expectancy
For dialysis after 5 years the mortality rate is 60 %. In contrast, for kidney transplantation it is 3 %.
A better quality of life
Quality of life is more than doubled. Clinical studies show 8 quality adjusted life years (QALY) for kidney transplantation, as opposed to just 3 QALY for dialysis.
For a 10 years period dialysis costs around 3 times more (>€900’000) then post-surgery care after kidney transplantation (>€300’000).
Our solution for kidney patients
organ.care is an initiative aimed at promoting organ donation. It is run by vita.coop, a Swiss patient cooperative offering a blockchain-based SaaS service to enable all citizens to create, manage, connect and execute their digital living wills. Worldwide, the living will is the legally binding document for organ donation. Organ donation registers are important, but complementary. With the organ.care campaign, we aim at empowering kidney patients to connect with organ donors, friends, family, insurers, doctors and other healthcare professionals in order to achieve our ambitious vision of zero time waiting lists.
Benefits for patients
- Reduction of waiting time
- Improvement of organ matching
- Improvement of quality of life
- Health literacy
- Saving of lives
Benefits for the community
- Reduction of overall costs
- Transparency for organ donors
- Improvement of organ donation process
Benefits for healthcare providers
- Improvement of transparency and efficiency of clinical workflows
- Improvement of decision making
- Improvement of communication
vita.coop‘s distributed ledger technology (DLT) service enables citizens to create, manage, connect and execute their digital living wills in a high security environment. Smart contracts support patients to connect with all relevant stakeholders and to guide them through healthcare workflows. It is designed to integrate frictionless into a patient-centric healthcare ecosystem, and unlocks the power of data-driven healthcare.
Some statistics for the European Union
43’000’000’000 € total annual hemodialysis cost in the European Union for 490’000 patients with ESRD.
patients in the European Union are on the waiting list.
kidneys have been donated for transplantation in the EU in 2017.
are the costs of dialysis during the average waiting time of 3 years before transplantation.
are the costs of a kidney transplantation including 3 years of post-surgery care.
patients die each year on the waiting list.
is the mortality rate of dialisys after 5 years.
is the mortality rate of transplantation after 5 years.
of the total healthcare costs are accounted by 1% of the population (ESRD kidney patients).
Dr. Marcos Garcia Pedraza
Execution Lead, Founder
Marcos lives in Switzerland, and is a Swiss-Spanish entrepreneur with over 20 years of experience in building technology-driven companies mainly in healthcare. He was trained in life sciences at the Swiss Federal Institute of Technology (ETH) in Zurich and entrepreneurship at Babson College in Boston, holds a PhD in business economics from the University of St.Gallen, and was honored with several awards, e.g. E&Y Entrepreneur of the Year 2002, SWITCH Innovation Award 2006 and Telefonica VIDA Award 2007. His passions are contemporary art and wild nature.
Communication Lead, Founder
He always had a passion for innovation and problem solving and has developed solutions to risk assessment and management whilst working as a helicopter pilot in remote camps. He has been flying as a bush pilot throughout the Canadian Arctic supporting mining exploration and in Western Africa as a VVIP pilot. A severe chronic illness forced him to change his career and he opted for a more “sedentary” but nevertheless challenging path. Paolo also served as a member of the Board of Directors at Lazzeri Agricola srl. Paolo is a graduate from the Swiss Federal Institute of Technology (ETH) in Zurich from where he obtained a MS degree in Biochemistry.
Technology Lead, Co-Founder
Ed (Abdul Wahed) Mehran is a skilled software engineer and entrepreneur. While graduating in informatics at USI in Lugano he created his first software startup for which he was awarded the Swiss Engineering Ticino Award 2014. He served as CTO for several companies and feels most rewarded when supporting other startups and founders succeed. He loves to be challenged with “unsolvable” problems to which he sticks to find the most viable solution. When he isn’t working, you can find Ed attending conferences in order to learn and grow. Ed joined organ.care in 2019.
IT Operations Lead, Co-Founder
Jan is an it professional and entrepreneur. After having graduated in computer science and business administration Jan worked in several international it projects before becoming partner in a swiss based it consulting company. Complex and challenging it projects as well as sustainable and reliable it operations are core competencies. Creating a digital cooperative which serves an imminent need for many people is Jans passion. He joined vita.coop/organ.care in 2019.
Dr. Erich Odermatt
Erich was trained in microbiology, biochemistry and biophysical chemistry. He has over 30 years of industrial experience in the development of medical devices, production, QA/QC, registration (class I to III), and execution of clinical studies phase I to IV in different countries. Erich is member of different professional committees and boards, and co-author of over 80 patents and 50 publications.
Alfonso has an extensive international experience in the field of insurance services. His expertise lies in several insurance-related fields such as: Primary insurance, life, accident & health insurance, reinsurance, alternative risk transfer, and risk & capital management. He was trained in physics at the Swiss Federal Institute of Technology Zürich (ETH) in Zurich and has an entrepreneurial spirit. Currently he works in Zürich for a multinational life insurer as head of underwriting.
Dr. Benjamin Ambar
Benjamin has considerable experience as an investor and is an accomplished serial entrepreneur. As an early crypto adopter he built up an extensive knowledge about blockchain and token economy.
He holds a Master in Neuroscience from ETH Zurich and a PhD in Biochemistry from University of Zurich.
HUMAN TRAFFICKING, THE HAITI FILES May 1, 2018 Organ trafficking is an undeniable worldwide issue that has been around since pharmaceuticals were first introduced in 1970 to prevent organ rejection, and quite possibly even earlier. The numbers speak for...
The state of the international organ trade: a provisional picture based on integration of available information
by Yosuke Shimazono Introduction Organ transplantation is an effective therapy for end-stage organ failure and is widely practised around the world. According to WHO, kidney transplants are carried out in 91 countries. Around 66 000 kidney transplants, 21 000 liver...
An opt-out register is unlikely to increase the number of organ donations because family members would be more likely to veto a presumed consent, researchers have said. The results of a study by Queen Mary University of London suggest that next of kin are more likely...